Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol

Authors: Debra Anderson, Charrlotte Seib, Dian Tjondronegoro, Jane Turner, Leanne Monterosso, Amanda McGuire, Janine Porter-Steele, Wei Song, Patsy Yates, Neil King, Leonie Young, Kate White, Kathryn Lee, Sonj Hall, Mei Krishnasamy, Kathy Wells, Sarah Balaam, Alexandra L. McCarthy

Published in: BMC Cancer | Issue 1/2017

Login to get access

Excerpt

After the publication of this work [1] errors were noticed in the Methods section of the Abstract. In the line “A single-blinded, multi-centre randomized controlled trial recruited a total of 330 women within 24 months of completion of chemotherapy (primary or adjuvant) and/or radiotherapy”, the number 330 should be corrected to 351. …
Literature
1.
Anderson D, Seib C, Tjondronegoro D, Turner J, Monterosso L, McGuire A, et al. The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer. 2017;17:98.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol
Authors
Debra Anderson
Charrlotte Seib
Dian Tjondronegoro
Jane Turner
Leanne Monterosso
Amanda McGuire
Janine Porter-Steele
Wei Song
Patsy Yates
Neil King
Leonie Young
Kate White
Kathryn Lee
Sonj Hall
Mei Krishnasamy
Kathy Wells
Sarah Balaam
Alexandra L. McCarthy
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3189-5

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Meta-analysis comparing laparoscopic versus open resection for gastric gastrointestinal stromal tumors larger than 5 cm

Review

A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies

Study protocol

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Research article

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer

Research article

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

Research article

African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits